Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation

Stefan Stojković, Johann Wojta(Medical University of Vienna), Christoph Neumayer(Vienna General Hospital), Cihan Ay(University of North Carolina at Chapel Hill), Sabine Rauscher(Medical University of Vienna), Wolfgang Holnthoner(Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA), Wolfgang Eppel(Medical University of Vienna), José Basílio(Medical University of Vienna), Svitlana Demyanets(Medical University of Vienna), Cornelia Bonstingl(Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA), Kurt Huber(Sigmund Freud Privatuniversität Wien), Lena Hell(Medical University of Vienna), Rainer de Martin(Deaconess Hospital), Marion Gröger(Medical University of Vienna), Konstantin A. Krychtiuk(Ludwig Boltzmann Institute for Cardiovascular Research), Christoph Kaun(University of Vienna), Ihor Huk(University of Vienna)
Scientific Reports
May 4, 2016
10.1038/srep25171
Cited by 88

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755
Polar secretion of endothelin-1 by cultured endothelial cells.
|Journal of Biological Chemistry|1992|645